NR3C2 and infectious otitis media: In a subsequent experiment, we added bethanechol, a non-subtype selective MR agonist, to the drinking water of 18 Arhgef7 CKO and 20 control mice for the 15 weeks after AOM/DSS treatment (Fig. 6a).